Kaerus Bioscience

Activities: Research & Development Digital

Trending Articles

  1. PolarSeal opens new medical device Innovation Lab at Farnborough headquarters The new facility will aim to accelerate early-stage development and de-risk next-generation medical devices, enabling MedTech teams to move from concept to scaled products faster
  2. Global myalgic encephalomyelitis study identifies 250+ core genes and shared biology with long COVID PrecisionLife’s large-scale genomic analysis reveals major biological drivers of ME and its overlap with long COVID, identifying dozens of drug repurposing opportunities and...
  3. Broughton launches ISO/IEC 17025-accredited methods for accurate cannabinoid analysis in oils and tinctures Broughton has introduced accredited HPLC-MS/MS methods to reliably quantify cannabinoids — including Total THC and Total CBD — in oils, tinctures and selected e-liquids,...
  4. Aenova appoints Alexandre Pasini as Chief Operating Officer Aenova announces the appointment of Alexandre Pasini as Chief Operating Officer (COO), effective November 1, 2025
  5. Vileda Professional CE At Vileda Professional CE we develop and manufacture leading edge cleaning solutions for professional users in various application areas, such as Healthcare and Controlled...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Research & Development

Servier acquires potential treatment for Fragile X syndrome

KER-0193, a novel, orally bioavailable small molecule, was granted orphan drug and rare paediatric drug designation by the US FDA
Research & Development

Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes
Subscribe now